Abstract
Amyloidosis are a group of diseases characterized by altered protein conformation, leading to the formation of fibrils that aggregate with non-protein substances and deposit extracellularly. These accumulations, called amyloids, can affect multiple organs simultaneously or only one organ.
Cardiac MRI is capable of providing a comprehensive evaluation of organ functionality by defining ejection volumes, perfusion, potential pericardial issues, and offering quantitative and qualitative data with high reproducibility, plays an important role in both the diagnosis and follow-up of patients with cardiac amyloidosis.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2024 Journal of Advanced Health Care